Latest News
Vanda Pharmaceuticals reports positive EMA opinion on orphan drug designation for imsidolimab in generalised pustular psoriasis
17 July 2026 - US pharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) announced on Thursday that the Committee for Orphan Medicinal Products at the European Medicines Agency (EMA) has adopted a positive opinion recommending orphan drug des...
Raidium introduces AI-powered oncology imaging workflow for US cancer centres
17 July 2026 - AI-native radiology company Raidium announced on Thursday the US launch of Raidium Read (R.Read), applying its AI-native imaging solution initially to oncology research centres.Raidium has already been deployed at Moffitt Cancer Center...
World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601
17 July 2026 - Clinical-stage biopharmaceutical company Spinogenix Inc announced on Thursday that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization has approved 'codabakalner' as the non-propriet...
Galmed announces breakthrough development of SCD1 inhibitor Aramchol for cardiac fibrosis
17 July 2026 - Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic and gastrointestinal oncology, announced on Thursday the breakthrough development of a new Aramchol-based lipid nano...
Circio and Avenue Biosciences launch research collaboration to improve protein secretion for gene therapy
16 July 2026 - Circio Holding ASA (OSE:CRNA), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, said on Thursday that it has entered into a research collaboration with protein engineering company A...